Newron
Italy · $39.7M raised
- Employees
- 51–200
- Business Model
- B2B
- Website
- newron.com
- Total Funding
- $39.7M
- Last Round
- $39.7M Corporate RoundFeb 2026
- Rounds
- 3
About
Newron Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for patients with CNS diseases and pain. The company approved product Xadago (safinamide) is a Parkinson disease treatment approved in over 20 markets worldwide.
Summary
Newron is a Biotech company based in Italy. It has raised $39.7M in total across 3 rounds, most recently a $39.7M Corporate Round round in Feb 2026. Investors include Omega Funds, 3i and TVM Capital.
Funding History
Feb 2026
Sign up to see all 3 rounds
Venture Round through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/newron"><img src="https://indexed.vc/api/badge/company/newron" alt="Newron on Indexed.vc" width="260" height="76" /></a>